Literature DB >> 21354811

Impact of Fontan conversion with arrhythmia surgery and pacemaker therapy.

Takeshi Hiramatsu1, Yusuke Iwata, Goki Matsumura, Takeshi Konuma, Kenji Yamazaki.   

Abstract

OBJECTIVE: In the long-term period after Fontan operation, atrial arrhythmia was one of the important factors to decide the postoperative quality of life. We reviewed the impact of Fontan conversion with arrhythmia surgery and pacemaker therapy.
METHODS: Thirty-eight patients underwent Fontan conversion using extracardiac conduit from 1992, and 22 patients with atrial arrhythmia underwent maze procedure simultaneously using cryoablation or radiofrequency ablation and epicardial DDD pacemaker implantation and 16 patients had regular 'sinus' rhythm before Fontan conversion. Mean follow-up period was 52 months. Pre- and postoperative clinical course were analyzed. Average weight, age at Fontan conversion, and years after first Fontan operation were 49.0 kg, 25.8 years old, 14.7 years, respectively. Nineteen percent of patients were in New York Heart Association class I (NYHA I), and 74% of patients were in NYHA II, and 7% were in NYHA III, respectively.
RESULTS: Except three early deaths, actual survival rate at 1 year and 5 years were 80% and 64%, respectively. In survivors, 80% of the patients obtained regular heart rhythm including artificial pacemaker rhythm, although only 43% of the patients had regular 'sinus' rhythm before the Fontan conversion. Postoperative average cardiothoracic ratio and oxygen saturation (SpO(2)) were 50% and 94%, and 74% of patients were in NYHA I and 26% were in NYHA II, respectively, after Fontan conversion.
CONCLUSIONS: Mid-term results of Fontan conversion with arrhythmia surgery and pacemaker therapy were acceptable. Restoration of regular rhythm might improve the postoperative NYHA status and the activity of the daily life.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21354811     DOI: 10.1016/j.ejcts.2011.01.022

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Outcomes of the Conversion of the Fontan-Kreutzer Operation to a Total Cavopulmonary Connection for the Failing Univentricular Circulation.

Authors:  Gabriel Carmona Fernandes; Guilherme Viotto Rodrigues da Silva; Luiz Fernando Caneo; Carla Tanamati; Aida Luiza Ribeiro Turquetto; Marcelo Biscegli Jatene
Journal:  Arq Bras Cardiol       Date:  2019-02       Impact factor: 2.000

Review 2.  The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.

Authors:  Ganesh K Gnanappa; David S Celermajer; Gary F Sholler; Tom Gentles; David Winlaw; Yves d'Udekem; Julian Ayer
Journal:  Pediatr Cardiol       Date:  2016-10-27       Impact factor: 1.655

Review 3.  Surgical treatment for adult congenital heart disease: consideration for indications and procedures.

Authors:  Kozo Matsuo; Masashi Kabasawa; Soichi Asano; Shigeru Tateno; Yasutaka Kawasoe; Yoshitomo Okajima; Naoki Hayashida; Hirokazu Murayama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-08

4.  The relationship of patient medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure.

Authors:  Brian W McCrindle; Victor Zak; Roger E Breitbart; Lynn Mahony; Peter Shrader; Wyman W Lai; Kristin M Burns; Steven D Colan; Richard V Williams; David Goldberg; Kevin D Hill; Svetlana Khaikin; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2013-11-22       Impact factor: 1.655

5.  Unscheduled hospitalization in adults with congenital heart disease.

Authors:  Jun Negishi; Hideo Ohuchi; Kenji Yasuda; Aya Miyazaki; Nakanishi Norifumi; Osamu Yamada
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

6.  Surgical outcomes of reoperation after Fontan completion.

Authors:  Yuki Nakayama; Takeshi Shinkawa; Ryogo Hoki; Hisashi Yoshida; Junko Katagiri; Kei Inai; Hiroshi Niinami
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.